Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001390478-16-000105
Filing Date
2016-04-28
Accepted
2016-04-28 18:07:52
Documents
1
Period of Report
2016-04-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2079
  Complete submission text file 0001390478-16-000105.txt   3741
Mailing Address 201 W 70TH ST, SUITE 23K NEW YORK NY 10023
Business Address
GRAY MARY ANN (Reporting) CIK: 0001261974 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33958 | Film No.: 161601578

Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations